Johnson Brady
- SEC CIK
- 0001751478
No open-market purchases or sales filed in the past year.
Current role at each company
- CDTX Cidara Therapeutics, Inc.Vice President, Financeas of Apr 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Johnson Brady as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Johnson BradyVice President, Finance | SSale | −654 | $0.81 | −$529.74 | −1.3%49.4K after | |
| Mar 11, 2022 (view filing) | Mar 11 | Same day | Johnson BradyVice President, Finance | SSale | −945 | $0.71 | −$670.95 | −1.9%50.0K after | |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Johnson BradyVice President, Finance | SSale | −416 | $1.25 | −$520 | −0.8%51.0K after |